Endocrinology, Vol 137, 90-95, Copyright © 1996 by Endocrine Society

ARTICLES

Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems

SW Rowlinson, MJ Waters, UJ Lewis and R Barnard
Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Australia.

Human GH (hGH) fragments 1-43 and 44-191 have potent in vivo effects on glucose homeostasis in rodents but cannot stimulate body growth. To assess the in vitro bioactivity of these hGH fragments we tested their activity against GH-responsive FDC-P1 cell lines expressing full-length human (h), mouse (m), or rabbit (r) GH receptors (GHR). Binding specificity and affinity was tested using GHR-containing membrane preparations from three species and recombinant hGH binding protein (hGHBP). Recombinant hGH 1-43 and recombinant 44-191 stimulated proliferation of FDC-P1-hGHR cells with half-maximal effect at approximately 2000 and 100 nM, respectively, whereas intact hGH stimulates proliferation of FDC-P1-hGHR cells with ED50 of 0.02-0.03 nM. However, these fragments had minimal effect on cells expressing mGHR or rGHR. Although 44-191 did not stimulate proliferation of FDC-P1- rGHR cells, when added to these cells in the presence of 0.23 nM hGH, it antagonized hGH action in a dose-dependent manner (ED50 at 230 nM). Binding of these GH fragments was compared using membrane preparations from rabbit liver, rabbit and mouse adipose tissue, and recombinant hGHBP. Binding competition curves were consistent, with 44-191 having at least a 10-fold lower affinity for rabbit liver GHR and rabbit adipose GHR than bovine GH and a 61-fold lower affinity for hGHBP than hGH. Binding of hGH 1-43 could not be demonstrated to GHRs in rabbit liver microsomes, adipose microsomes, or to hGHBP. HGH 1-43 did not compete for insulin binding sites in adipose microsomes. In conclusion, hGH 44-191 binds with low affinity to the GHR and at supraphysiologic levels stimulates proliferation of FDC-P1-hGHR cells. At high doses, 44- 191 can also antagonize GH action in FDC-P1-rGHR cells, presumably by blocking receptor dimerization. Binding of 1-43 to GHR could not be detected, and the basis for its weak in vitro mitogenic effect remains to be elucidated. The low affinity of the fragments for cloned GHRs and low biopotency in these systems suggests that the metabolic actions of these fragments are unlikely to be mediated by the cloned GHR. This raises the possibility of a separate receptor mediating metabolic effects of these fragments.

This article has been cited by other articles:

				W. J. Kraemer, B. C. Nindl, J. O. Marx, L. A. Gotshalk, J. A. Bush, J. R. Welsch, J. S. Volek, B. A. Spiering, C. M. Maresh, A. M. Mastro, et al. Chronic resistance training in women potentiates growth hormone in vivo bioactivity: characterization of molecular mass variants Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1177 - E1187. [Abstract] [Full Text] [PDF]

				A. V. Filikov, R. J. Hayes, P. Luo, D. M. Stark, C. Chan, A. Kundu, and B. I. Dahiyat Computational stabilization of human growth hormone Protein Sci., June 1, 2002; 11(6): 1452 - 1461. [Abstract] [Full Text] [PDF]

				W. C. Hymer, W. J. Kraemer, B. C. Nindl, J. O. Marx, D. E. Benson, J. R. Welsch, S. A. Mazzetti, J. S. Volek, and D. R. Deaver Characteristics of circulating growth hormone in women after acute heavy resistance exercise Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E878 - E887. [Abstract] [Full Text] [PDF]

				B. C. Nindl, W. C. Hymer, D. R. Deaver, and W. J. Kraemer Growth hormone pulsatility profile characteristics following acute heavy resistance exercise J Appl Physiol, July 1, 2001; 91(1): 163 - 172. [Abstract] [Full Text] [PDF]

				J. D. Wallace, R. C. Cuneo, M. Bidlingmaier, P. A. Lundberg, L. Carlsson, C. L. Boguszewski, J. Hay, M.-L. Healy, R. Napoli, R. Dall, et al. The Response of Molecular Isoforms of Growth Hormone to Acute Exercise in Trained Adult Males J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 200 - 206. [Abstract] [Full Text]

				M. A. Heffernan, W. J. Jiang, A. W. Thorburn, and F. M. Ng Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E501 - E507. [Abstract] [Full Text] [PDF]

				A. Herman, D. Helman, O. Livnah, and A. Gertler Ruminant Placental Lactogens Act as Antagonists to Homologous Growth Hormone Receptors and as Agonists to Human or Rabbit Growth Hormone Receptors J. Biol. Chem., March 19, 1999; 274(12): 7631 - 7639. [Abstract] [Full Text] [PDF]

				C. L. Boguszewski, P.-A. Svensson, T. Jansson, R. Clark, L. M. S. Carlsson, and B. Carlsson Cloning of Two Novel Growth Hormone Transcripts Expressed in Human Placenta J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2878 - 2885. [Abstract] [Full Text]

				J. L. Walker, P. A. Crock, S. N. Behncken, S. W. Rowlinson, L. M. Nicholson, T. J. C. Boulton, and M. J. Waters A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2554 - 2561. [Abstract] [Full Text]

				D. Helman, N. R. Staten, J. Grosclaude, N. Daniel, C. Nespoulous, J. Djiane, and A. Gertler Novel Recombinant Analogues of Bovine Placental Lactogen. G133K AND G133R PROVIDE A TOOL TO UNDERSTAND THE DIFFERENCE BETWEEN THE ACTION OF PROLACTIN AND GROWTH HORMONE RECEPTORS J. Biol. Chem., June 26, 1998; 273(26): 16067 - 16074. [Abstract] [Full Text] [PDF]

				S. W. Rowlinson, S. N. Behncken, J. E. Rowland, R. W. Clarkson, C. J. Strasburger, Z. Wu, W. Baumbach, and M. J. Waters Activation of Chimeric and Full-length Growth Hormone Receptors by Growth Hormone Receptor Monoclonal Antibodies. A SPECIFIC CONFORMATIONAL CHANGE MAY BE REQUIRED FOR FULL-LENGTH RECEPTOR SIGNALING J. Biol. Chem., February 27, 1998; 273(9): 5307 - 5314. [Abstract] [Full Text] [PDF]

				D. Helman, N. R. Staten, J. Byatt, J. Grosclaude, R. E. McKinnie, J. Djiane, and A. Gertler Site-Directed Mutagenesis of Recombinant Bovine Placental Lactogen at Lysine-73 Leads to Selective Attenuation of Its Somatogenic Activity Endocrinology, October 1, 1997; 138(10): 4069 - 4080. [Abstract] [Full Text] [PDF]

				C. L. Boguszewski, C. Jansson, M. C. S. Boguszewski, S. Rosberg, B. Carlsson, K. Albertsson-Wikland, and L. M. S. Carlsson Increased Proportion of Circulating Non-22-Kilodalton Growth Hormone Isoforms in Short Children: A Possible Mechanism for Growth Failure J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2944 - 2949. [Abstract] [Full Text] [PDF]

				C. L. Boguszewski, G. Johannsson, B.-A. Bengtsson, A. Johansson, B. Carlsson, and L. M. S. Carlsson Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1516 - 1521. [Abstract] [Full Text] [PDF]